Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial
ClinicalTrials.gov study NCT00995293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT02110992. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07125755. IPD Sharing: NO. Countries: 1. Publications: 0.
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
ClinicalTrials.gov study NCT02678884. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer
ClinicalTrials.gov study NCT06232863. IPD Sharing: NO. Countries: 1. Publications: 0.
Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor
ClinicalTrials.gov study NCT04831320. IPD Sharing: NO. Countries: 1. Publications: 0.
Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06161545. IPD Sharing: YES. Countries: 1. Publications: 0.
Serum Squamous Cell Carcinoma Antigen Level and Tumor Volume in Head and Neck Cancer
ClinicalTrials.gov study NCT02879968. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07156227. IPD Sharing: YES. Countries: 0. Publications: 0.
A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03433027. IPD Sharing: YES. Countries: 2. Publications: 0.
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Imm
ClinicalTrials.gov study NCT06208826. IPD Sharing: NO. Countries: 1. Publications: 0.
A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck
ClinicalTrials.gov study NCT04597476. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05668858. IPD Sharing: NO. Countries: 1. Publications: 0.
Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation
ClinicalTrials.gov study NCT03510390. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04843098. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT01484847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers
ClinicalTrials.gov study NCT04180215. IPD Sharing: NO. Countries: 3. Publications: 0.
GB1211 and Pembrolizumab Versus Pembrolizumab and Placebo in Patients With Metastatic Melanoma and Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05913388. IPD Sharing: NO. Countries: 1. Publications: 0.
Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With
ClinicalTrials.gov study NCT06869473. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
ClinicalTrials.gov study NCT07136545. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.